Press Releases

PITTSBURGH, May 31, 2024 /PRNewswire/ -- "I wanted to create a handy spray to sanitize metal surfaces and reduce contact with germs and viruses," said an inventor, from Moreno Valley, Calif., "so I invented the IRRESISTIBLE. My design can be easily applied onto any metal object, such as a handrail, door handle or pole, and it would serve as a more fragrant alternative to traditional disinfectants."

... (continue reading...)

HOLMDEL, N.J., May 31, 2024 /PRNewswire/ -- Morgan Samuels, a leading executive search platform, announced today the addition of Eric Tenety as a Senior Client Partner based in New York. With a career spanning over 20 years, Eric has established himself as a trusted adviser to investors, founders and operators of world class companies.

Eric joins Morgan... (continue reading...)

BusinessRocket (+1-310-424-5558) has expanded its TCP license application service throughout California, providing a fully managed solution for companies that offer public transportation services.

Los Angeles, United States - May 31, 2024 —

Charter bus companies, limousine hire firms, and shuttle service providers in California can now outsource the new business application process and get professional assistance with everything from choosing the right structure to... (continue reading...)

SAN JOSE, Calif.--(BUSINESS WIRE)-- On May 31, 2024, Techpoint, Inc. (“Techpoint”) announced that on May 30, 2024, its board of directors declared the second installment payment of its cash dividend of an aggregate of $0.50 per share for fiscal 2024, of which $0.25 per share was paid to stockholders in February 2024. The second installment on shares of its common stock (including common stock underlying its Japanese Depositary Shares ("JDS")) will be paid on or... (continue reading...)

mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes

CAMBRIDGE, MA / ACCESSWIRE / May 31, 2024 / Moderna, Inc. (NASDAQ: MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine, to protect adults aged 60 years and older from lower respiratory tract disease caused by RSV infection. The approval was granted under a... (continue reading...)